ING1 antibody
Principal name
ING1 antibody
Alternative names for ING1 antibody
Inhibitor of growth protein 1, ING-1
Ncbi ID
NP_005528.3, NP_937862, 9606, NP_005528, NM_198219, NP_937861, NM_198218, NM_005537, NP_036049.2, NM_011919, NM_198217
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P), EPair for Elisa (EPair), ELISA (detection) (E(detection)), Immunoprecipitation (IP)
Background of ING1 antibody
- Kit Component:
- - KN308326G1, Ing1 gRNA vector 1 in pCas-Guide vector
- KN308326G2, Ing1 gRNA vector 2 in pCas-Guide vector
- KN308326D, donor vector containing left and right homologous arms and GFP-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
1. Campos,E.I., Chin,M.Y., Kuo,W.H. and Li,G. (2004) Biological functions of the ING family tumor suppressors. Cell. Mol. Life Sci. 61 (19-20). 2597-2613.
2. Cheung,K.J. Jr. and Li,G. (2002) p33(ING1) enhances UVB-induced apoptosis in melanoma cells. Exp. Cell Res. 279 (2), 291-298.
3. Vieyra,D. et al (2002) Human ING1 proteins differentially regulate histone acetylation. J. Biol. Chem. 277 (33), 29832-29839.
4. Nagashima,M. et al (2001) DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc. Natl. Acad. Sci. U.S.A. 98 (17), 9671-9676.
5. Shinoura,N. et al (1999) Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. Cancer Res. 59 (21), 5521-5528.
6. Garkavtsev,I., Grigorian,I.A., Ossovskaya,V.S., Chernov,M.V., Chumakov,P.M. and Gudkov,A.V. (1998) The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391 (6664), 295-298.
7. Helbing,C.C., Veillette,C., Riabowol,K., Johnston,R.N. and Garkavtsev,I. (1997) A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res. 57 (7), 1255-1258.
8. Garkavtsev,I. and Riabowol,K. (1997) Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor.
Mol. Cell. Biol. 17 (4), 2014-2019.
9. Garkavtsev,I., Demetrick,D. and Riabowol,K. (1997) Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1).
Cytogenet. Cell Genet. 76 (3-4), 176-178.
10. Garkavtsev,I., Kazarov,A., Gudkov,A. and Riabowol,K. (1996) Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14 (4), 415-420.






















- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA590316 | ING1 antibody |
||||||
| Rabbit Polyclonal ING1 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Mky, Ms, Rt | E, ICC/IF, P, WB |
0.1 mg /
€409.00
|
|
| OriGene Technologies, Inc. | |||||||
+6 additional images |
Highly validated antibody! |
||||||
| TA319418 | ING1 antibody |
||||||
| Goat polyclonal anti-p33 ING1 antibody | |||||||
![]() |
Goat | Aff - Purified | Hu, Ms, Rt | E, WB |
0.1 mg /
€515.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA326481 | ING1 antibody |
||||||
| Rabbit Polyclonal Anti-p33 ING1 Antibody | |||||||
![]() |
Rabbit | IgG | Serum | Hu, Ms | E, ICC/IF, WB |
0.4 ml /
€400.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA350698 | ING1 antibody |
||||||
| Rabbit Polyclonal Anti-ING1 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP07596PU-N | ING1 antibody |
||||||
![]() |
Goat | Aff - Purified | Hu | E, ICC/IF, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
| R1608CP | ING1 Control Peptide |
||||||
![]() |
Purified |
50 µg /
€205.00
|
|||||
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP317763 | ING1 (transcript variant 1) |
||||
| Recombinant protein of human inhibitor of growth family, member 1 (ING1), transcript variant 1 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760507 | ING1 (full length, N-term HIS tag, transcript variant 2) |
||||
| Purified recombinant protein of Human inhibitor of growth family, member 1 (ING1), transcript variant 2, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug | |||||
![]() |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY403677 | ING1 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY404951 | ING1 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY430724 | ING1 overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC217763L2V | Lenti ORF particles, ING1 (mGFP-tagged) - Human inhibitor of growth family, member 1 (ING1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,020.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR225175L2V | Lenti ORF particles, Ing1 (GFP-tagged) - Mouse inhibitor of growth family, member 1 (Ing1), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||















+6 additional images





